Rights and permissions
About this article
Cite this article
Costs of prolonged motor weakness after neuromuscular blockers. Pharmacoecon. Outcomes News 89, 8 (1996). https://doi.org/10.1007/BF03270414
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03270414